RE:RE:I hope you all realize...thorgb1 wrote: HowSheGoingEhh wrote: that CMED share price is what it is because of Aurora.. if you think that is not true then I feel sorry for you. Please tell me what they have done to increase their shareprice since the beginning of the takeover talk...
All I got is the pharma thing...was there more....?
Wow, just, wow. This isn't really an argument you can make since the stock traded $10 above the ACB offer. This really doesn't even justify a response, but, okay........
-exclusive agreement to distribute to PharmaChoice's 700+ locations
-Europen distribution with initial access to 22K pharmacies
-rec platform via HIP, which had a $B market cap a week ago, for a fraction of that
At $35 its undervalued still.
This doesn't really justify a response, but, okay.......
While you're listed news may have added value to Cannimed and their share price. They would not be where they are without Aurora. That's a fact!
- January 2017 to November 2017 - $13.10 peak
- Since the Aurora takeover news - $32.11
- When news was released about the PharmaChoice deal, CMED went up a whopping .43c (and then returned the following day)
- HIP adds very little value, CMED shareholders do NOT want them....Zettl does....and is merely delaying the inevitable
CMED management throughout this process has been unprofessional and at times, petty. Aurora are 99% the driving force of the current CMED shareprice
IMO